Literature DB >> 22492734

Dissociative changes in the Bmax and KD of dopamine D2/D3 receptors with aging observed in functional subdivisions of the striatum: a revisit with an improved data analysis method.

Hiroto Kuwabara1, Mary E McCaul, Gary S Wand, Christopher J Earley, Richard P Allen, Elise M Weerts, Robert F Dannals, Dean F Wong.   

Abstract

UNLABELLED: Separate measurements of B(max), the density of available receptors, and K(D), the equilibrium dissociation constant in the human brain, with PET have contributed to our understanding of neuropsychiatric disorders, especially with respect to the dopamine D(2)/D(3) receptor system. However, existing methods have limited applications to the whole striatum, putamen, or caudate nucleus. Improved methods are required to examine B(max) and K(D) in detailed functional striatal subdivisions that are becoming widely used.
METHODS: In response, a new method (bolus-plus-infusion transformation [BPIT]) was developed. After completion of a validation study for (11)C-raclopride scans involving 81 subjects, age-associated changes in B(max) and K(D) were examined in 47 healthy subjects ranging in age from 18 to 77 y.
RESULTS: The BPIT method was consistent with established reference tissue methods regarding regional binding potential. BPIT yielded time-consistent estimates of B(max) and K(D) when scan and infusion lengths were set equal in the analysis. In addition, BPIT was shown to be robust against PET measurement errors when compared with a widely accepted transient equilibrium method. Altogether, BPIT was supported as a method for regional binding potential, B(max), and K(D). We demonstrated age-associated declines in B(max) in all 5 functional striatal subdivisions with BPIT when corrected for multiple comparisons. These age-related effects were not consistently attainable with the transient equilibrium method. Irrespective to methods, K(D) remained unchanged with age.
CONCLUSION: The BPIT approach may be useful for understanding dopamine receptor abnormalities in neuropsychiatric disorders by enabling separate measurements of B(max) and K(D) in functional striatal subdivisions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492734      PMCID: PMC4533866          DOI: 10.2967/jnumed.111.098186

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  39 in total

1.  Column-switching HPLC for the analysis of plasma in PET imaging studies.

Authors:  J Hilton; F Yokoi; R F Dannals; H T Ravert; Z Szabo; D F Wong
Journal:  Nucl Med Biol       Date:  2000-08       Impact factor: 2.408

2.  Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.

Authors:  Yanjun Wu; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2002-12       Impact factor: 6.200

3.  Effects of age on dopamine D2 receptor availability in striatal subdivisions: a high-resolution positron emission tomography study.

Authors:  Jong-Hoon Kim; Young-Don Son; Hang-Keun Kim; Sang-Yoon Lee; Seo-Eun Cho; Young-Bo Kim; Zang-Hee Cho
Journal:  Eur Neuropsychopharmacol       Date:  2011-04-20       Impact factor: 4.600

Review 4.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

5.  Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.

Authors:  Masanori Ichise; Jeih-San Liow; Jian-Qiang Lu; Akihiro Takano; Kendra Model; Hiroshi Toyama; Tetsuya Suhara; Kazutoshi Suzuki; Robert B Innis; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2003-09       Impact factor: 6.200

6.  Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.

Authors:  Diana Martinez; Mark Slifstein; Allegra Broft; Osama Mawlawi; Dah-Ren Hwang; Yiyun Huang; Thomas Cooper; Lawrence Kegeles; Eric Zarahn; Anissa Abi-Dargham; Suzanne N Haber; Marc Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2003-03       Impact factor: 6.200

7.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

8.  Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations.

Authors:  H Watabe; C J Endres; A Breier; B Schmall; W C Eckelman; R E Carson
Journal:  J Nucl Med       Date:  2000-03       Impact factor: 10.057

9.  Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.

Authors:  Dean F Wong; James R Brasić; Harvey S Singer; David J Schretlen; Hiroto Kuwabara; Yun Zhou; Ayon Nandi; Marika A Maris; Mohab Alexander; Weiguo Ye; Olivier Rousset; Anil Kumar; Zsolt Szabo; Albert Gjedde; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2007-11-07       Impact factor: 7.853

10.  Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey.

Authors:  E Ehrin; L Farde; T de Paulis; L Eriksson; T Greitz; P Johnström; J E Litton; J L Nilsson; G Sedvall; S Stone-Elander
Journal:  Int J Appl Radiat Isot       Date:  1985-04
View more
  7 in total

1.  Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.

Authors:  Yoshiteru Takekita; Chiara Fabbri; Masaki Kato; Shinpei Nonen; Shiho Sakai; Naotaka Sunada; Yosuke Koshikawa; Masataka Wakeno; Gaku Okugawa; Toshihiko Kinoshita; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-28       Impact factor: 5.270

Review 2.  Brain-iron deficiency models of restless legs syndrome.

Authors:  Christopher J Earley; Byron C Jones; Sergi Ferré
Journal:  Exp Neurol       Date:  2022-06-30       Impact factor: 5.620

3.  An integrative model of Parkinson's disease treatment including levodopa pharmacokinetics, dopamine kinetics, basal ganglia neurotransmission and motor action throughout disease progression.

Authors:  Florence Véronneau-Veilleux; Philippe Robaey; Mauro Ursino; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-10-21       Impact factor: 2.745

4.  Increased synaptic dopamine in the putamen in restless legs syndrome.

Authors:  Christopher J Earley; Hiroto Kuwabara; Dean F Wong; Charlene Gamaldo; Rachel E Salas; James R Brašić; Hayden T Ravert; Robert F Dannals; Richard P Allen
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

5.  18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography.

Authors:  Feng Hu; Patrick J Morris; Jordi Bonaventura; Hong Fan; William B Mathews; Daniel P Holt; Sherry Lam; Matthew Boehm; Robert F Dannals; Martin G Pomper; Michael Michaelides; Andrew G Horti
Journal:  Eur J Med Chem       Date:  2020-11-25       Impact factor: 6.514

6.  Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.

Authors:  Anne S Berry; Vyoma D Shah; Daniella J Furman; Robert L White; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Mark D'Esposito; William J Jagust
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853

7.  Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.

Authors:  Hiroto Kuwabara; Stephen J Heishman; James R Brasic; Carlo Contoreggi; Nicola Cascella; Kristen M Mackowick; Richard Taylor; Olivier Rousset; William Willis; Marilyn A Huestis; Marta Concheiro; Gary Wand; Dean F Wong; Nora D Volkow
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.